Efficacy of individualized dose regimens of isosorbide-5-mononitrate (Multitab®) in patients with angina

Advances in Therapy

Volumn 16, Issue 6, 1999, Pages 263-271

  Vaccarella, Alvaro ^a  

^a NONE   (Italy)

Author keywords

Angina; Isosorbide 5 mononitrate; Multitab ; Tailored therapy; Tolerance

Indexed keywords

ISOSORBIDE 5 NITRATE; MONOKET MULTITAB; NITRATE; UNCLASSIFIED DRUG;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED RELEASE FORMULATION; CORONARY ARTERY DISEASE; DRUG EFFICACY; DRUG INDUCED DISEASE; EXERCISE TEST; FEMALE; HEADACHE; HUMAN; MALE; TREATMENT OUTCOME;

EID: 0033383076     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Murrel W. Nitroglycerine as a remedy for angina pectoris. Lancet. 1879;1:80-81;113-115;151-152; 225-227.
2. Parker JD, Parker JO. Nitrate therapy for stable angina pectoris. N Engl J Med. 1998;38:520-531.
3. Brown BG, Bolson E, Petersen RB, Pierce CD, Dodge HT. The mechanism of nitroglycerin action: stenosis vasodilatation as a major component of drug response. Circulation. 1981;64:1089-1097.
4. Goller V, Clausen M, Henze E, et al. Reduction of exercise-induced myocardial perfusion defects by isosorbide-5-nitrate: assessment using quantitative Tc-99m-MIBI-SPECT. Coron Artery Dis. 1995;6:245-249.